Pregabalin for the Prevention of Chemotherapy Induced Nausea and Vomiting
Status:
Unknown status
Trial end date:
2020-02-28
Target enrollment:
Participant gender:
Summary
phase II randomized, double-blind, placebo-controlled trial to investigate whether pregabalin
can improve the complete control of nausea and vomiting (primary end point)